The WHO has urgently approved Abbott Laboratories’ mpox diagnostic test amid rising global cases. The Alinity m MPXV assay detects the virus from skin lesion swabs, aiding rapid testing in outbreak regions. It marks a crucial step in controlling the spread, especially in underserved areas. Vulnerable groups, including children and those with weakened immune systems, face higher risks.